Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 1:53 pm Purchase | 2024-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Samlyn Capital, LLC | 6,667,105 9.800% | 403,347 (+6.44%) | Filing History |
| 2025-02-13 4:30 pm Purchase | 2024-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Richard A. Miller | 5,220,368 7.700% | 1,536,358 (+41.70%) | Filing History |
| 2024-08-01 9:18 pm Sale | 2024-08-01 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Samlyn Capital, LLC | 6,263,758 9.990% | -4,226 (-0.07%) | Filing History |
| 2024-05-13 4:52 pm Purchase | 2024-05-01 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Samlyn Capital, LLC | 6,267,984 9.990% | 3,771,725 (+151.10%) | Filing History |
| 2024-05-09 5:29 pm Purchase | 2024-05-02 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Point72 Asset Management, L.P. | 17,050,384 9.900% | 17,050,384 (New Position) | Filing History |
| 2024-05-08 7:55 pm Unchanged | 2024-05-06 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 6,943,654 11.100% | 0 (Unchanged) | Filing History |
| 2024-02-14 1:31 pm Purchase | 2023-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Samlyn Capital, LLC | 2,496,259 5.100% | 2,496,259 (New Position) | Filing History |
| 2024-02-13 6:27 pm Purchase | 2023-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Richard A. Miller | 3,684,010 7.190% | 578,889 (+18.64%) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -3,101,709 (Position Closed) | Filing History |
| 2023-02-13 12:01 pm Purchase | 2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | CHI Advisors LLC | 2,384,402 5.120% | 2,384,402 (New Position) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Richard A. Miller | 3,105,121 6.450% | 497,973 (+19.10%) | Filing History |
| 2023-01-30 4:17 pm Sale | 2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Integrated Core Strategies (US) LLC | 1,899,516 4.100% | -1,020,543 (-34.95%) | Filing History |
| 2022-02-14 4:15 pm Sale | 2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Venrock Healthcare Capital Partners II, L.P. | 250,000 0.500% | -3,177,461 (-92.71%) | Filing History |
| 2022-02-14 4:00 pm Purchase | 2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | TANG CAPITAL MANAGEMENT, LLC | 3,101,709 6.700% | 3,101,709 (New Position) | Filing History |
| 2022-02-11 7:30 pm Sale | 2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | BIOTECHNOLOGY VALUE FUND L P | 1,370,947 3.000% | -1,527,850 (-52.71%) | Filing History |
| 2022-02-11 5:55 pm Purchase | 2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Richard A. Miller | 2,607,148 5.450% | 427,589 (+19.62%) | Filing History |
| 2022-01-18 4:55 pm Purchase | 2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Integrated Core Strategies (US) LLC | 2,920,059 6.300% | 403,531 (+16.04%) | Filing History |
| 2021-12-06 4:44 pm Purchase | 2021-12-01 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Integrated Core Strategies (US) LLC | 2,516,528 5.400% | 487,927 (+24.05%) | Filing History |
| 2021-11-03 3:03 pm Unchanged | 2021-11-02 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 6,943,654 14.900% | 0 (Unchanged) | Filing History |
| 2021-10-22 4:36 pm Purchase | 2021-10-12 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Integrated Core Strategies (US) LLC | 2,028,601 4.800% | 2,028,601 (New Position) | Filing History |